3 reports

Journal of Clinical Pathology - Molecular Pathology; ##(##): ##-## Nelson AL and Reichert JM (2009).

  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • Genmab group
  • Johnson & Johnson
  • Deal in Brief

Summary Genmab A/S (Genmab) is a biotechnology company that develops differentiated human antibody therapeutics for the treatment of cancer. The company’s marketed antibody, ofatumumab (Arzerra) and Daratumumab (Darzalex) are used to treat chronic lymphocytic leukemia and to treat patients with multiple myeloma respectively. Genmab’s...

  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • United States
  • Genmab group
  • PARTNERSHIPS
  • PARTNERSHIPS

The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pathology, dermatopathology, hematopathology and prostate pathology.

  • Healthcare
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Genmab group